share_log

China Pharma | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Nov 4, 2022 16:33
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more